17.04.2007 04:01:00
|
Study Shows CDHP Financial Incentives Not Enough to Change Consumer Behavior
Consumer-Directed Health Plans (CDHP) require more than financial
incentives to help consumers make smart choices about their health and
prescription use, according to a new study by pharmacy benefit manager
Express Scripts.
CDHP participants were, in fact, less likely than traditional health
plan enrollees to change behavior and take advantage of cost-saving
generic drugs. The Express Scripts study found that CDHP participants
simply curtailed brand-medication use instead of consistently
substituting generic for brand medications.
"CDHPs do not automatically produce more
cost-effective behavior,” said Glen Moller,
vice president of product development, Express Scripts. "Our
research shows that consumers need more and better tools to make
prescription drug choices that maximize both health and financial
outcomes. At Express Scripts, we are leveraging our success with
consumer engagement in traditional pharmacy benefits to promote
utilization of the most clinically-effective and cost-effective
medications by CDHP enrollees.”
The Express Scripts study reviewed the results of two national employers
that began offering a CDHP as a benefit option in January 2006 –
without such consumer tools. The study, involving 19,500 enrollees of
employer A and 14,600 enrollees of employer B, examined prescription
claims during the first nine months of 2005 and 2006 respectively. At
both employers, it compared CDHP and traditional pharmacy benefit plan
experiences. A significant number of employees enrolled in the CDHP
plans: 36 percent for employer A and 22 percent for employer B.
While implementation of a CDHP produced considerable prescription-drug
cost savings, the main source of savings came from cost-shifting as
enrollees paid a greater proportion of their drug costs through high
CDHP deductibles. Utilization decreases and higher enrollee payments
associated with the CDHPs led to net-plan cost reductions of 62 percent
and 24 percent for Employers A and B, respectively.
Although CDHP enrollees at both companies reduced their use of brand
medications by about 13-14 percent following enrollment, those
reductions were not offset by increases in generic-medication use.
Meanwhile, enrollees in traditional pharmacy benefit plans increased
their use of lower-cost generic drugs, while their use of brand drugs
remained unchanged from 2005 to 2006, resulting in net utilization
increases.
On a per-enrollee basis, growth in generic claims for Employer A’s
traditional plan more than doubled that of the CDHP, 18.6 percent vs.
7.5 percent. At Employer B, the per-enrollee growth in generic claims
for the traditional plan was 17 percent but only 13 percent for the
CDHP. According to the study, which is available at http://www.express-scripts.com/ourcompany/news/outcomesresearch/
onlinepublications, the findings suggest a role for better education
of CDHP enrollees. (Due to its length, this URL may need to be
copied/pasted into your Internet browser's address field. Remove the
extra space if one exists.)
Within traditional pharmacy benefit plans in 2006, Express Scripts saved
plan sponsors and patients $126 million just through greater use of
generic cholesterol-lowering drugs. By the end of the year, 40 percent
of all cholesterol-lowering prescriptions at Express Scripts were for
generic simvastatin, lovastatin and pravastatin, up from 8 percent at
the beginning of 2006.
Contributing significantly to this success was a comprehensive,
multi-faceted consumer behavior change program that encouraged patients
to ask their physician about low-cost generic medication options
available to treat high cholesterol. The programs included tailored
communications and decision assistance timed for greatest relevance and
ease of use. Express Scripts now offers plan sponsors a similar
education program for use with CDHP enrollees.
Included in the program are broad-based enrollee communications, such as
a web-based tool for checking drug prices and savings opportunities. In
addition, targeted patient-specific communications inform enrollees
using high-cost medications about savings available from generics.
Enrollees using home delivery also get an outbound call before a
high-cost medication is dispensed. To ensure chronically ill enrollees
continue taking their medications, letters are sent to both enrollees
and their physicians when a gap in claims activity is detected.
"The pharmacy benefit is ripe for consumerism
and offers a great opportunity for members to take a more active role in
managing their healthcare decisions, but it takes advice from a trusted
expert” said Moller. "The
pharmacy benefit is typically a patient’s
first encounter with the health benefit in a given year; it happens
primarily in a non-emergency situation; there many available
alternatives to treat most conditions; and when the plan member is not
satisfied with his/her decision, it is relatively easy to make a
different decision the next month. Through better communications and
tools, we are able to take advantage of these teachable moments to help
members raise their ‘Pharmacy IQ.’”
Express Scripts also supports CDHPs by providing seamless data
integration with plan sponsors’ medical
carriers. This allows medical and pharmacy claims data to be shared at
any frequency, up to and including real time, to manage and track
combined CDHP accumulators like deductibles and out-of-pocket maximums.
Express Scripts currently integrates data for CDHPs with more than 50
national, regional and local carriers, health plans and third-party
administrators.
Express Scripts, Inc. (Nasdaq: ESRX) is one of the largest pharmacy
benefit management (PBM) companies in North America, providing PBM
services to more than 50 million patients through facilities in 13
states and Canada. Express Scripts serves thousands of client groups,
including managed-care organizations, insurance carriers, third-party
administrators, employers and union-sponsored benefit plans. Express
Scripts is headquartered in St. Louis, Missouri. More information can be
found at http://www.express-scripts.com.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu Express Scripts Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Express Scripts Inc.mehr Analysen
Indizes in diesem Artikel
NASDAQ Comp. | 19 926,72 | 0,12% | |
S&P 500 | 6 051,09 | 0,00% | |
NASDAQ 100 | 21 780,25 | 0,76% |